Nizoral (ketoconazole) faces lawsuits highlighting potential risks like liver damage, adrenal gland insufficiency, and heart rhythm issues. Concerns stem from studies and user experiences, prompting legal action against the manufacturer, Johnson & Johnson. Patients should weigh these risks with their healthcare providers.
| Complete Date | Case | Citation | Court | Short Summary |
|---|---|---|---|---|
| Ongoing | Multiple Individual Lawsuits | Not publicly available (ongoing litigation) | Various U.S. District Courts | Individuals claim Nizoral caused liver damage, adrenal insufficiency, or heart rhythm problems, seeking compensation from Johnson & Johnson. |
| Varied | Specific dates and details vary across individual cases. | |||
| 2013 | FDA Safety Communication | Not applicable | N/A | FDA warns of increased risk of liver injury with Nizoral, recommending dose limitations and monitoring. |
| Pre-2013 | Various Studies | Medical journals | N/A | Studies suggest potential link between Nizoral and liver damage, adrenal issues, and heart rhythm irregularities. |
Current Status:
- Individual lawsuits against Johnson & Johnson are ongoing, with no overall verdict or resolution.
- The FDA continues to advise caution with Nizoral and recommends monitoring for liver issues.
- No specific class action lawsuit against Nizoral is currently active.
Legal Implications and Patient Considerations:
- The lawsuits highlight potential risks associated with Nizoral use.
- Patients should discuss potential benefits and risks with their healthcare providers before using Nizoral.
- Alternative treatment options should be explored if necessary.
Additional Notes:
- This information does not constitute legal advice. Consult with a qualified legal professional for specific legal inquiries.
- The details and outcomes of individual lawsuits may vary.
